Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in mild to moderate hypertension
NCT00157326Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in hypertension (HTN), sponsored by Eli Lilly and Company. Started Sep 2005; status: completed.
02
Drugs
tadalafil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00157326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157326.